telabio.com (TELA) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of TELA Bio Inc. (TELA)

TELA Bio, Inc. (TELA) automates implant production using CNC machines and AI-driven fiber control. The long-term financial leverage ratio demonstrates that the indicator stands at 0.00, linking borrowed funds to equity. Management is implementing innovative materials to displace synthetics, while the company gradually expands its general surgery device portfolio to reduce its narrow specialization in tissue reconstruction.

TELA telabio.com: Long-Term Debt to Equity in the range 07/04/2022 - 10/30/2026

Analytical breakdowns for TELA Bio, Inc.

- share price and consensus valuation forecast:
Price TELA Bio Corp|TELA - Analyst Consensus Forecast
- market capitalization indicators:
Market Value TELA Bio, Inc.|TELA - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share TELA Bio|TELA - Company Book Value|Market Value to Book Value telabio.com|TELA - Company Total Assets
- debt and solvency information:
Total Debt to Capital TELA Bio, Inc.|TELA - Long-Term Debt to Equity|Current Liabilities to Equity TELA Bio Corp|TELA - Company Aggregate Debts|Debts to Book Value TELA Bio, Inc.|TELA - Company Long-Term Liabilities|Company Short-Term Debts TELA Bio|Intermediate Liquidity Ratio telabio.com
- business earnings and investment ratios data:
TELA - Net Profit
Summary company analysis:TELA (telabio.com)
Core merchandise of TELA Bio Inc.

The long-term debt-to-equity ratio assesses financial stability by analyzing long-term liabilities relative to shareholders' equity. The dynamics of the long-term debt-to-net assets ratio allow for a real-time assessment of the credit load based on market quotes. This metric is calculated as the ratio of loans with a maturity of more than one year to the total value of capital. For TELA Bio, Inc. (TELA), this balance is critical when scaling OviTex biomimetic technologies. Debt control ensures the stable implementation of innovative implants into surgical practice.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|CytoSorbents Corp. - Long-Term Debt to Capital|Long-Term Liabilities to Capital Sensus|ZYXI: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ECOR|RBOT (Vicarious Surgical Inc) - Long-Term Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ICU|Long-Term Debt to Equity Ratio iridex.com IRIX|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Long-Term Debt to Capital Beyond Air Inc XAIR|PFSA - Long-Term Debt to Equity|SSKN: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)